Daiichi Sankyo, AstraZeneca sign $6.9 billion cancer drug deal

AstraZeneca Plc and Japan’s Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi’s cancer drug trastuzumab deruxtecan.

…read more

Read more here: Daiichi Sankyo, AstraZeneca sign $6.9 billion cancer drug deal

Category: businessNews

Leave a Reply

%d bloggers like this: